Washington bets on equity, Brussels writes strategies: the quantum gap is now a choice

On Thursday, the US Department of Commerce announced that the federal government will take equity stakes in nine quantum-computing companies, mobilising around $2 billion in public capital under the CHIPS and Science Act. IBM gets $1 billion to set up Anderon, the first dedicated American facility for manufacturing quantum chips, in New Albany, New York.

GlobalFoundries takes $375 million in exchange for a federal stake of about 1%. D-Wave, Rigetti and Infleqtion each get around $100 million; Diraq up to $38 million. Shares in the listed firms rose between 6% and 31% on the day.

Commerce Secretary Howard Lutnick framed the deal as a step “to build on our domestic industry, creating thousands of high-paying American jobs while advancing American quantum capabilities”. The language is industrial-policy boilerplate. What sits behind it isn’t.

A new industrial policy in plain sight

Quantum computing isn’t yet a commercial market. Nvidia’s Jensen Huang said only last year that “very useful quantum computers” were probably two decades away. Error rates remain high and use cases remain speculative.

Yet Washington has chosen exactly this moment, precisely because the science isn’t settled, to plant a flag. The federal government is no longer subsidising R&D from a distance. It is taking equity, picking winners and assembling a domestic supply chain before China locks in scale.

It’s the same logic that produced the 10% federal stake in Intel last year and the strategic position in MP Materials, the rare-earth miner. Three sectors — advanced chips, critical minerals and quantum — have been folded into a single industrial doctrine. The government buys in, sits at the table and protects what it considers strategic. Whatever one thinks of the politics, the direction of travel is unmistakable.

Europe’s quantum effort, by the numbers

Now put that $2 billion, committed in a single day, against Europe’s quantum effort. The EU’s flagship programme, launched in 2018, runs on a €1 billion budget over ten years. France’s Plan Quantique commits roughly €1.8 billion across the decade, Germany’s national strategy around €3 billion, and the Netherlands €615 million through Quantum Delta NL.

Italy participates through PNRR-funded research consortia and work coordinated by the CNR and INFN. The Commission itself now puts total public funding mobilised over five years at around €11 billion across EU institutions and Member States.

Not a small number. But add it carefully. Each programme has its own governance, funding cycle, preferred national champions and procurement rules.

There is no European Anderon. No European stake in a European quantum chip manufacturer. No European vehicle capable of taking equity in a strategic technology company at the scale Washington just did.

None, at least, that is not constrained by state-aid rules, national prerogatives and the sheer slowness of satisfying twenty-seven shareholders at once. One figure captures the result, and it comes from the Commission itself: European quantum companies attract only around 5% of global private investment.

Why €11 billion buys less than $2 billion

The gap is not really about money. Europe does not lack funds in aggregate; the Commission counts some €11 billion mobilised over five years. The problem is what that money has to travel through before it reaches a company.

In Europe, funding moves along separate channels, each with its own logic. Horizon Europe funds research consortia, national plans back domestic champions, the European Investment Bank lends to mid-caps, and EuroHPC pays for shared computing infrastructure. Every channel works on its own terms. None of them, alone or combined, amounts to a single balance sheet capable of deciding to own part of a strategic company.

That is what the headline numbers obscure. When Washington decides quantum chips are strategic, one actor signs a $1 billion cheque and takes equity for the taxpayer in the same week.

When Brussels reaches the same conclusion, no single actor can move. It adopts a strategy — the Quantum Europe Strategy of 2 July 2025 — announces a Quantum Act for 2026 and waits for twenty-seven Member States to align, assuming they ever do. The firepower exists. What is missing is a trigger.

The Quantum Europe Strategy itself acknowledges that the EU is “lagging behind in translating its innovation capabilities and future potential into real market opportunities, while also struggling with fragmentation of strategies and roadmaps across Member States”.

The diagnosis is correct. The instruments proposed — pilot chip lines, a quantum design facility, a skills academy and a Quantum Talent Mobility Programme — are useful but insufficient if the real problem is that no European actor can sign a cheque comparable to the one Washington just signed.

What focus would actually mean

Changing approach is not a slogan. It means three concrete things.

First, accepting that some technologies are strategic enough for European public capital to take equity stakes, rather than merely handing out grants and tax credits. The instruments already exist: the EIB, the European Investment Fund, a reformed STEP platform and the Scaleup Europe Fund launched in May 2025. What is missing is the political will to use them.

Second, choosing. Europe cannot fund every Member State quantum champion, every national photonics lab and every parallel cryogenic-chip programme. Concentration is the price of relevance.

Third, building the manufacturing layer, not only the research one. The American move matters precisely because it targets the chip-fabrication bottleneck. Europe still possesses world-class assets — IMEC in Leuven, CEA-Leti in Grenoble and the Fraunhofer institutes — but lacks a joint plan to scale them.

None of this is incompatible with European values, single-market rules or competition law. What it is incompatible with is the comforting assumption that excellence in research will automatically become industrial leadership. It did not happen with cloud computing. It did not happen with AI accelerators. There is no reason to assume quantum will be different.

A choice, not a fate

The $2 billion announced in Washington this week is not, by Silicon Valley standards, a vast sum. It will look modest next to the private capital likely to follow it. What matters is the signal. The world’s most powerful economy has decided to use its balance sheet as an instrument of technological sovereignty and is now competing for the next general-purpose technology not as a regulator, but as a shareholder.

Europe still has the talent, the public-research base and the industrial heritage to do the same. What it lacks today is the institutional muscle to act with the speed and concentration the moment demands.

The quantum gap is not yet a verdict. It is a choice.

As Infleqtion’s Matthew Kinsella told Reuters, quantum is “coming much faster than anybody thinks”. If he is right, the window in which Europe can still make a different choice may be narrower than Brussels appears willing to admit.